Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACSL1 | P33121 | 2/20 | 0.51 |
| ▸ | ACSL6 | Q9UKU0 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 8/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.47 |
| ▸ | BCHE | P06276 | 7/20 | 0.47 |
| ▸ | ACHE | P22303 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9804075 | 0.80 | BCHE (0.48) | ACSL1ACSL6MAOBHRH3BCHE | |
| SCHEMBL7397081 | 0.77 | ACSL1 (0.56) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL7405337 | 0.77 | ACSL1 (0.56) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL9804088 | 0.76 | LMNA (0.47) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL9804039 | 0.76 | LMNA (0.47) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL9804000 | 0.75 | LMNA (0.49) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL9804091 | 0.74 | NPSR1 (0.50) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL5579221 | 0.74 | LMNA (0.62) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL5390554 | 0.74 | LMNA (0.58) | ACSL1ACSL6NPC1MAPTMAOB | |
| SCHEMBL16806176 | 0.72 | LMNA (0.60) | ACSL1ACSL6NPC1MAPTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5026848-A | Antirhinovirus agents | SYNPHAR LABORATORIES INCORPORATED (CA) | 1991-06-25 | — | — | US | claimed |
| US-5026848-A | Antirhinovirus agents | SYNPHAR LABORATORIES INCORPORATED (CA) | 1991-06-25 | — | — | US | disclosed |
| EP-0335636-A1 | Antiviral compounds | SYNPHAR LABORATORIES INC. (CA) | 1989-10-04 | — | — | EP | disclosed |